Skip to main content
SpringerLink
Log in

Acitretin/fluticasone-propionate/sars-cov-2-vaccine-inactivated-sinovac-biotech

Pityriasis-rubra-pilaris and lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Zhang L-W, et al. Pityriasis rubra pilaris following inactivated SARS-CoV-2 vaccine (CoronaVac). Journal of the European Academy of Dermatology and Venereology 37: e287-e288, No. 3, Mar 2023. Available from: URL: http://doi.org/10.1111/jdv.18768

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Acitretin/fluticasone-propionate/sars-cov-2-vaccine-inactivated-sinovac-biotech. Reactions Weekly 1963, 18 (2023). https://doi.org/10.1007/s40278-023-42074-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-42074-9

Search

Navigation